Production (Stage)
Mydecine Innovations Group Inc.
MYCO
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 78.63% | 84.75% | -3.31% | -7.49% | -4.28% |
| Total Depreciation and Amortization | -- | -- | -100.00% | -92.91% | -90.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -85.79% | -93.36% | 479.97% | 414.93% | 318.34% |
| Change in Net Operating Assets | -66.41% | -54.73% | -19.74% | -19.56% | 6.82% |
| Cash from Operations | 99.23% | 99.15% | 93.16% | 91.74% | 85.51% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -100.00% | -94.50% |
| Cash from Investing | -- | -- | -100.00% | -100.00% | -94.26% |
| Total Debt Issued | -- | -- | 7.11% | 7.11% | 307.41% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -94.07% | -94.05% | -86.89% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -91.39% | -91.36% | -84.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -194.59% | -234.01% | 159.51% | 43.50% | 165.49% |